1. Chimeric antigen receptor T-cell therapy for acute lymphocytic leukaemia: where are we in 2020?. Issue 11 (November 2020) Authors: Laetsch, Theodore W Journal: Lancet Issue: Volume 7:Issue 11(2020) Page Start: e778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (12th November 2021) Authors: Doz, François; van Tilburg, Cornelis M; Geoerger, Birgit; Nysom, Karsten; Øra, Ingrid; Boni, Valentina; Chisholm, Julia; Chung, Hyun Cheol; DuBois, Steven G; Melcón, Soledad Gallego; Gerber, Nicolas U; Goto, Hiroaki; Grilley-Olsen, Juneko E; Hansford, Jordan R; Hong, David S; Italiano, Antoine; K... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (14th November 2022) Authors: Perreault, Sébastien; Drilon, Alexander; Lassen, Ulrik N; Geoerger, Birgit; Nysom, Karsten; Øra, Ingrid; Gavrilovic, Igor T; Norenberg, Ricarda; Bernard-Gauthier, Vadim; De La Cuesta, Esther; Laetsch, Theodore W; Doz, François; Van Tilburg, Cornelis M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET. (9th November 2020) Authors: Perreault, Sébastien; Doz, François; Drilon, Alexander; Geoerger, Birgit; Boni, Valentina; Chisholm, Julia; Dubois, Steven G; Grilley-Olson, Juneko E; Hong, David S; Italiano, Antoine; Kang, HyoungJin; Nysom, Karsten; Øra, Ingrid; Owens, Cormac; Schulte, Johannes H; Tahara, Makoto; Ziegler, David... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Issue 6 (27th November 2021) Authors: Doz, François; van Tilburg, Cornelis M; Geoerger, Birgit; Højgaard, Martin; Øra, Ingrid; Boni, Valentina; Capra, Michael; Chisholm, Julia; Chung, Hyun Cheol; DuBois, Steven G; Gallego-Melcon, Soledad; Gerber, Nicolas U; Goto, Hiroaki; Grilley-Olson, Juneko E; Hansford, Jordan R; Hong, David S; It... Journal: Neuro-oncology Issue: Volume 24:Issue 6(2022) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS. (4th December 2020) Authors: Goto, Hiroaki; Geoerger, Birgit; DuBois, Steven G; Grilley-Olson, Juneko E; van Tilburg, Cornelis M; Schulte, Johannes; Kang, Hyoung Jin; Tahara, Makoto; Boni, Valentina; Perreault, Sebastien; Capra, Michael; Reeves, John A; Brega, Nicoletta; Childs, Barrett H; Laetsch, Theodore W; Ziegler, David... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion. (3rd June 2022) Authors: Lamoureux, Audrey-Anne; Fisher, Michael; Lemelle, Lauriane; Pfaff, Elke; Kramm, Christof; De Wilde, Bram; Kazanowska, Bernarda; Hutter, Caroline; Pfister, Stefan M; Sturm, Dominik; Jones, David; Orbach, Daniel; Pierron, Gaëlle; Raskin, Scott; Drilon, Alexander; Diamond, Eli; Harada, Guilherme; Za... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours. (3rd June 2022) Authors: Nysom, Karsten; Doz, François; Geoerger, Birgit; Øra, Ingrid; Perreault, Sebastien; Norenberg, Ricarda; Fellous, Marc; De La Cuesta, Esther; Laetsch, Theodore W; van Tilburg, Cornelis M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunoglobulin replacement and quality of life after CAR T-cell therapy – Authors' reply. Issue 1 (January 2020) Authors: Laetsch, Theodore W; Harris, Andrew C Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Issue 5 (May 2018) Authors: Laetsch, Theodore W; DuBois, Steven G; Mascarenhas, Leo; Turpin, Brian; Federman, Noah; Albert, Catherine M; Nagasubramanian, Ramamoorthy; Davis, Jessica L; Rudzinski, Erin; Feraco, Angela M; Tuch, Brian B; Ebata, Kevin T; Reynolds, Mark; Smith, Steven; Cruickshank, Scott; Cox, Michael C; Pappo, ... Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗